Improving CAR-T cell therapy for brain tumors using focused ultrasound
Official title: Novel approaches to enrich CAR-T cell Therapy in brain tumors using focused ultrasound
Funded at Univ of North Carolina Chapel Hill · NIH-10997390 · Data updated 2026-11-12
This study is looking at how using focused ultrasound can help CAR-T cell therapy work better for people with glioblastoma, a type of brain tumor, by making it easier for the treatment to reach and attack the tumor cells in the brain.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $211,773 |
| NIH project number | 5R21CA286897-02 |
| Project ID | NIH-10997390 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with glioblastoma who are seeking innovative treatment options.
✕Less likely to help
Patients with brain tumors other than glioblastoma or those who are not eligible for CAR-T cell therapy may not benefit from this research.
What this research studies
This research investigates how focused ultrasound (FUS) can enhance the effectiveness of CAR-T cell therapy for treating glioblastoma, a type of brain tumor. By using FUS, the researchers aim to temporarily disrupt the blood-brain barrier, allowing CAR-T cells to better penetrate brain tissue and target tumor cells. The study involves advanced biomedical engineering techniques and aims to improve the delivery of these innovative therapies to patients with brain tumors. The approach is based on promising early studies that have shown the potential of FUS in enhancing drug delivery to the brain.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment outcomes for patients with glioblastoma by enhancing the effectiveness of CAR-T cell therapy.
How similar studies have gone: Other studies have shown success with focused ultrasound in enhancing drug delivery to the brain, making this approach promising yet still innovative.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Dayton, Paul a — Univ of North Carolina Chapel Hill
- Study coordinator: Dayton, Paul a
Related research
Other NIH-funded projects on the same topics.
-
Implantable scaffolds to make CAR‑T therapy stronger and cheaper for brain tumors
This project aims to use a biocompatible implant placed at the tumor site to help CAR‑T immune cells reach and kill glioblastoma cells while reducing the need for repeated, costly infusions.
-
Developing new scaffolds to improve CAR-T cell therapy for brain tumors
This study is looking at a new way to make CAR-T cell therapy work better for people with glioblastoma, a tough brain tumor, by using special scaffolds to help deliver the treatment right to the tumor, so patients can get more effective care.
-
Enhancing CAR T cell therapy for brain tumors
This study is looking at ways to make CAR T cell therapy better for people with high grade gliomas, a tough type of brain tumor, by tweaking the T cells to help them fight the tumor more effectively.
-
Improving drug delivery to brain tumors using focused ultrasound and vascular normalization
This study is exploring a new way to help deliver cancer-fighting drugs more effectively to brain tumors by using focused ultrasound and tiny bubbles, which could make treatments work better for patients.
-
Modulating deep brain activity with focused ultrasound for cocaine use disorder
A study will test whether targeting a deep brain region with focused ultrasound can alter brain signals related to craving in people with cocaine use disorder.
-
Dose-Dependent Brain Wire Modulation with Light Ultrasound in Deep White Matter
A small early study tests whether gentle, noninvasive ultrasound can change how deep brain white matter tracts work in healthy adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.